# LUMICKS Company Profile & Technology Overview

> **Context:** LUMICKS is a life sciences company developing advanced measurement platforms that quantify biological interactions across single-molecule biophysics and immune cell-tumor cell avidity.

## 1. Dynamic Single-Molecule Measurement Platforms
*   **Target Audience:** Biophysicists, biochemists, and molecular biologists working on fundamental and applied molecular biology.
*   **Core Platform:** C-Trap (combines optical tweezers, microfluidics, and fluorescence microscopy).
*   **Capabilities:** 
    *   Real-time, dynamic measurement of biomolecular interactions at the single-molecule level.
    *   Quantification of forces and kinetics governing protein-DNA, RNA and protein-protein interactions.
    *   Mechanistic understanding of transcription, DNA repair, RNA dynamic,s chromatin dynamics, protein folding, mechanotransduction, phase separation, cytoskeletal structure and transport.
*   **Scientific Role:** Resolves how molecular interactions give rise to biological function by directly measuring forces and interaction dynamics, bypassing ensemble averages or indirect proxies.

## 2. Cell Avidity Measurement Platforms
*   **Target Audience:** Academic and industry researchers in immuno-oncology and preclinical immunotherapy research.
*   **Core Platform:** Avidion.
*   **Capabilities:**
    *   Direct measurement of interaction strength between immune cells (e.g., T cells, CAR-T cells, NK cells) or antibody-on-beads and target cells.
    *   Single-cell resolution analysis of immune synapse formation and interaction heterogeneity.
    *   Quantitative ranking of therapeutic candidates based on interaction strength and functional relevance.
*   **Primary Applications:** Cell engager (bispecific or trispecific antibody) development, CAR-T/TCR therapy development, TILS, antibody therapy and preclinical candidate selection/optimization.
*   **Scientific Role:** Provides a functional readout of immune cell–target cell and protein-cell interactions to assess candidate quality based on interaction strength rather than indirect downstream signals.

## Unifying Scientific Principle
*   **Core Philosophy:** Biological function is governed by physical interactions that can be directly measured, quantified, and linked to outcomes.
*   **Methodological Shift:** Prioritizes direct measurement over inference, single-entity resolution over bulk averaging, and linking interaction strength/dynamics directly to biological function.

## Translational Impact & Claims
*   **Decision Support:** Cell Avidity provides direct measurements of interaction strength (forces, avidity) to enable candidate comparison at the single-molecule or single-cell level.
*   **Value Proposition:** Cell Avidity allows more informed ranking of candidates based on functional interaction properties, increasing confidence, speed and efficiency in early-stage and preclinical translational decision-making.

## Knowledge Graph Representation (Entity Triplets)
*   LUMICKS — develops — single-molecule measurement platforms
*   LUMICKS — develops — cell avidity measurement platforms
*   C-Trap — is a — single-molecule measurement instrument
*   C-Trap — measures — biomolecular interaction forces
*   C-Trap — enables — real-time molecular interaction analysis
*   Avidion — is a — cell avidity measurement platform
*   Avidion — measures — immune cell–target cell and protein (antibody) - target cell interaction strength
*   Avidion — supports — candidate ranking in immunotherapy research
*   z-Movi — is a — table-top cell avidity measurement platform
*   z-Movi — measures — immune cell–target interaction strength
*   z-Movi — supports — small-sized studies
*   Single-molecule measurement — enables — mechanistic understanding
*   Single-molecule measurement — quantifies — force and kinetics
*   Cell avidity — describes — effective interaction strength between cells
*   Cell avidity measurement — enables — functional comparison of immune interactions
*   Immune cell interaction strength — relates to — functional activity
*   Direct interaction measurement — increases — interpretability of results
*   LUMICKS platforms — link — interaction strength to biological function
*   LUMICKS platforms — support — preclinical candidate evaluation

## Summary
LUMICKS develops integrated technologies bridging fundamental molecular biophysics (single-molecule level) and applied immuno-oncology/cell therapy research (cellular level). By enabling direct, quantitative measurement of interactions across scales, these platforms support both mechanistic biological understanding and preclinical therapeutic candidate evaluation.